AIH - Aesthetic Medical International and investors enter share purchase and other agreements

• Aesthetic Medical International ( NASDAQ: AIH ), founders, Dr. Pengwu Zhou and Ms. Wenting Ding and certain other existing controlled by the Founders and Australia Wanda International company entered into a share purchase agreement .
• Pursuant to the agreement, Seefar Global, Jubilee Set Investments, and Pengai Hospital Management agreed to sell and Wanda as the buyer agreed to purchase, an aggregate of ~21.32M ordinary shares for the total consideration equivalent of RMB100M, representing a price of RMB4.67 per share.
• The transfer is expected to close in Q4 2022.
• Founders and Hainan Oriental Jiechuang Investment Partnership also entered into a subscription agreement , whereby Jiechuang agrees to subscribe an aggregate of ~36.4M newly issued ordinary shares for consideration equivalent of RMB170M, representing a subscription price of RMB4.67 per share.
• Expected to close during Q4 2022.
• Company, the founders, Seefar, Jubilee and certain other parties entered shareholders’ agreement whereby company shall deliver two separate warrants to purchase ordinary shares of the company to Seefar and Wanda, respectively, on the date of completion of closings of both the share transfer and subscription of ordinary shares by Jiechuang.

For further details see: